MOLSON COORS BEV B DL0,01/ US60871R2094 /
31.05.2024 21:43:01 | Diff. +0,950 | Volumen | Geld21:59:58 | Brief21:59:58 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
50,200EUR | +1,93% | 8 Umsatz: 398,160 |
50,440Geld Vol: 295 | 50,580Brief Vol: 295 | 10,2 Mrd.EUR | - | - |
GlobeNewswire
02:38
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
01:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02.06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02.06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02.06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite